The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Author Title Type [ Year(Asc)]
Filters: Author is Akriviadis, Evangelos  [Clear All Filters]
2017
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Oikonomou, T., Goulis I., Soulaidopoulos S., Karasmani A., Doumtsis P., Tsioni K., et al. (2017).  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 217-224.
Kalafateli, M., Zisimopoulos K., Vourli G., Rigamonti C., Goulis J., Manesis E., et al. (2017).  Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.. Dig Dis Sci. 62(5), 1363-1372.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.
2015
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.. Ann Gastroenterol. 28(3), 374-378.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Authors' reply.. Ann Gastroenterol. 28(4), 507.
Manolakopoulos, S., Kranidioti H., Goulis J., Vlachogiannakos J., Elefsiniotis J., Kouroumalis E. A., et al. (2015).  Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.. Ann Gastroenterol. 28(4), 481-6.
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Dimopoulou, D., Dimitroulas T., Akriviadis E., & Garyfallos A. (2015).  Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis.. Rheumatol Int. 35(11), 1913-6.
Goulis, I., Karatapanis S., Akriviadis E., Deutsch M., Dalekos G. N., Raptopoulou-Gigi M., et al. (2015).  On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.. Liver Int. 35(5), 1540-8.
Papalavrentios, L., Sinakos E., Chourmouzi D., Hytiroglou P., Drevelegas K., Constantinides M., et al. (2015).  Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis.. Ann Gastroenterol. 28(1), 118-123.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.